Delivery Order SPE2DB22D2009-SPE2DB25FM0VH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $30,963.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, carries a firm fixed price and has an ultimate completion date of August 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $3,096.33 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion deadline of August 21, 2025. This is a firm fixed price, non-set-aside contract, with performance based in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, demonstrating the company's role as a critical vaccine...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.03 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 26, 2025, utilizes firm fixed pricing and carries an ultimate completion date of September 17, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 14, 2025, for Varivax vaccine with diluents to be delivered to Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0VHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $105,296 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with performance at the company's Conshohocken, Pennsylvania location. The contract employs firm fixed price pricing and carries an ultimate completion date of September 3, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to fulfill federal medical procurement requirements. This award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The parent IDC serves multiple government entities including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key strategic pharmaceutical supplier for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $105.3k | 8/12/25 |